Alle Storys
Folgen
Keine Story von Schweizerischer Nationalfonds / Fonds national suisse mehr verpassen.

Schweizerischer Nationalfonds / Fonds national suisse

SNSF opposes initiative to ban animal and human experimentation

Bern, 14.10.2021 (ots)

The Swiss National Science Foundation (SNSF) strives consistently and continuously to improve the quality of research. A ban on animal and human experiments would massively restrict the opportunity to gain knowledge and adversely affect Switzerland as a research hub.

On 13 February 2022, the Swiss electorate will vote on the initiative to ban animal and human experiments. Acceptance of the initiative would severely restrict research on both animals and humans. This would impact clinical research as well as experiments in psychology and sports science, among other areas. In addition, research on how farm animals and pets should be kept and what medical care they should receive would no longer be allowed.

Obstructing medical progress

Animal testing is still necessary to develop new medical treatments. Alternative methods, such as cell cultures, are not always an option. What is more, newly developed drugs and treatments need to be tested on healthy volunteers for safety reasons, and their efficacy must be assessed in comparison with groups of people who were administered a placebo. If accepted, the initiative would significantly hinder researchers' efforts to improve medical treatments.

In the event of a complete ban on animal testing and research on humans, Switzerland would be unable to keep pace with international research. For these reasons, the SNSF supports the position taken by the Swiss higher education institutions (swissuniversities) and the Swiss Academies, which is to reject the initiative.

Advancing the 3R principles

Based on its high quality standards for research projects, the SNSF complies with the "3R" principles for the humane treatment of animals. These guidelines, developed by the research community and decreed by the federal government, stipulate that whenever possible animal experiments should be replaced by alternative approaches ("replace"), the number of animals should be kept as small as possible ("reduce") and the animals should be subjected to as little stress as possible ("refine"). The research community is constantly working to improve these approaches.

With this in mind, in May 2021 the SNSF launched a call for the National Research Programme "Advancing 3Rs - Animals, Research and Society" in accordance with its government mandate. The programme aims to shed light on the tensions surrounding animal welfare and to improve biomedical research. The projects to be funded will be chosen in April 2022. The research phase will last until 2027, and the programme will publish its final report and recommendations in November 2028.

Improving clinical trials

The SNSF also promotes high quality standards in clinical research. The special programme for Investigator Initiated Clinical Trials (IICT) supports clinical studies on underresearched topics that fill both a medical and a social need. Though important for patients, such study topics remain outside the focus of industry. In 2021, representatives of patient organisations are having a say in project selection for the first time. The SNSF has thus ensured that the submitted projects adequately address the needs of patients.

In addition, the MD-PhD programme and the Protected Research Time for Clinicians initiative support research-oriented physicians. BioLink promotes the networking of biobanks, thereby facilitating research into diseases. The SNSF also co-funds the Swiss Clinical Trial Organisation, which aims to improve the quality of clinical trials. The wellbeing of individuals takes precedence over science and society through the Swiss Federal Human Research Act and the Helsinki Declaration, signed by Switzerland.

Links

The text of this press release and further information are available on the website of the Swiss National Science Foundation: www.snsf.ch > What's new > Press releases

Contact:

Swiss National Science Foundation
Communication division
Wildhainweg 3
CH-3001 Bern
Tel.: +41 31 308 23 87
Email: com@snf.ch

Weitere Storys: Schweizerischer Nationalfonds / Fonds national suisse
Weitere Storys: Schweizerischer Nationalfonds / Fonds national suisse
  • 06.10.2021 – 08:00

    Detecting microplastics in the environment

    Bern (ots) - Geochemist Denise Mitrano has found a way to track how micro- and nanoplastic particles spread through the environment. For this work, she is receiving this year's Marie Heim-Vögtlin Prize from the Swiss National Science Foundation. Man-made plastic pollutes the environment. When broken down into micro- and nanoparticles, it poses an increasing problem not only for the oceans and their inhabitants, but also ...

  • 14.07.2021 – 08:00

    Cancerous tumours: how likely are they to metastasise?

    Bern (ots) - A very aggressive type of cancer has provided a team of researchers supported by the Swiss National Science Foundation with an answer to the question of which tumour cells are at risk of spreading. Cancer treatment is sometimes complicated by the heterogeneity of the cells that form the tumour mass. The problem is how to identify the few cells that are capable of triggering metastases. Thanks to work carried ...

  • 13.07.2021 – 08:00

    Clinical research: patients and the public have their say

    Bern (ots) - The Swiss National Science Foundation has been funding clinical studies on under-researched topics in medicine since 2016. In a first, it successfully involved representatives of patients and the public in evaluating applications. The aim of the SNSF's Investigator Initiated Clinical Trials (IICT) programme is to answer medical questions that are important to society but not a priority for industry. This ...